Kentucky Opioid Response Effort (KORE)
- KORE-funded agencies
- HEALing Communities Study Wave 1 agencies
- Orders will be filled where possible for all other Kentucky agencies.
The current evidence indicates that naloxone 4mg nasal spray (ie. Narcan) is an effective dose and route of administration for opioid overdose reversal.
The 0.4mg / mL product is supplied as single use glass vials with one dose per vial. Your agency would need to supply intramuscular syringes with this product.
TRAININGTo receive overdose reversal agents such as NARCAN® Nasal Spray through KORE, all requesting agencies must be trained in overdose education. Training focuses on recognizing/responding to an overdose, basic tenets of addiction, opioid exposures, roles of treatment, and harm reduction programs. And can be accessed here:
Additional training (either in person or virtual) can be requested by submitting the Naloxone Request Form in the section below.
Kentucky agencies (including Local Health Departments) can request naloxone by utilizing the following process:
Step 1: Click HERE to access the Naloxone Request Form.
Step 2: Complete the KORE Request Form. Be sure to indicate if training is being requested.
Step 3: Approved requests will be shipped to the requesting agency with 2 weeks.
Guided by the Recovery-Oriented System of Care Framework, the purpose of the Kentucky Opioid Response Effort (KORE) is to implement a comprehensive targeted response to Kentucky’s opioid crisis by expanding equitable access to a full continuum of high quality, evidence-based opioid prevention, harm reduction, treatment, and recovery supports. For more information, visit kore.ky.gov